Hidradenitis supurativa en niños

1. Velpeau A. Dictionnaire de medecine, un repertoire general des sciences medicales sous la rapport theorique et practique. In: Aisselle. Vol. 2. 2nd ed. Paris, France: Bechet Jeune; 1833

2. Verneuil A. Etudes sur les tumeurs de la peau; des quelques maladies des glandes sudoriparies. Arch Gen Med.1854;5(4):447–468

3. Verneuil A. De l’hidrosadenite phlegmoneuse et des abces sudoripares. ArchGen Med.1864;2:537–557

4. Brunsting HA. Hidradenitis suppurativa; abscess of the apocrine sweat glands. Arch Derm Syphilol. 1939;39:108–120

5. Shelley WB, Cahn MM. The pathogenesis of hidradenitis suppurativa in man. Arch Dermatol. 1955;72(6):562–565

6. Von Der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol. 2000;142(5):947–953

7. Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76–90

8. Zouboulis CC, Del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GB. Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology. 2015;231(2):184–190

9. Kittler NW, Williams JC, Kudlinski MV, et al. Evaluation of hidradenitis suppurativa diagnostic criteria in pediatric patients. JAMA Dermatol. 2022;158(12): 1404–1408

10. Liy-Wong C, Kim M, Kirkorian AY, et al. Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients. JAMA Dermatol. 2021;157(4):385–391

11. Calao M, Wilson JL, Spelman L, et al. Hidradenitis suppurativa (HS) prevalence, demographics and management pathways in Australia: a population-based cross-sectional study. PLoS One. 2018;13(7): e0200683

12. Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V. Population-based clinical practice research datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol. 2018;178(4):917–924

13. Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153(8): 760–764

14. Garg A, Wertenteil S, Baltz R, Strunk A, Finelt N. Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis. J Invest Dermatol. 2018;138(10): 2152–2156

15. Saunte DML, Jemec GBE. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017;318(20): 2019–2032

16. Hallock KK, Mizerak MR, Dempsey A, Maczuga S, Kirby JS. Differences between children and adults with hidradenitis suppurativa. JAMA Dermatol. 2021;157(9):1095–1101

17. Naik HB, Paul M, Cohen SR, Alavi A, Suarez-Farinas M, Lowes MA. Distribution of self-reported hidradenitis suppurativa age at onset. JAMA Dermatol.2019;155(8):971–973

18. Molina-Leyva A, Cuenca-Barrales C. Adolescent-onset hidradenitis suppurativa: prevalence, risk factors and disease features. Dermatology. 2019;235(1):45–50

19. Scheinfeld N. Hidradenitis suppurativa in prepubescent and pubescent children. Clin Dermatol. 2015;33(3):316–319

20. Deckers IE, van der Zee HH, Boer J, Prens EP. Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement. J Am Acad Dermatol. 2015;72(3):485–488

21. Braunberger TL, Nicholson CL, Gold L, et al. Hidradenitis suppurativa in children: the Henry Ford experience. Pediatr Dermatol. 2018;35(3):370–373

22. Shao K, Hooper J, Feng H. Racial and ethnic health disparities in dermatology in the United States. Part 2: disease-specific epidemiology, characteristics, management, and outcomes. J Am Acad Dermatol. 2022;87(4):733–744

23. Cullen MR, Lemeshow AR, Russo LJ, Barnes DM, Ababio Y, Habtezion A. Disease-specific health disparities: a targeted review focusing on race and ethnicity. Healthcare (Basel). 2022; 10(4):603

24. Vossen ARJV, van der Zee HH, Prens EP.

Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model.Front Immunol. 2018;9:2965

25. Navrazhina K, Frew JW, Gilleaudeau P, Sullivan-Whalen M, Garcet S, Krueger JG. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa. J Allergy Clin Immunol. 2021;147(6):2213–2224

26. Ring HC, Thorsen J, Saunte DM, et al. The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls. JAMA Dermatol. 2017;153(9):897–905

27. Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18

28. Guet-Revillet H, Coignard-Biehler H, Jais JP, et al. Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis. 2014;20(12):1990–1998

29. Zouboulis CC, Benhadou F, Byrd AS, et al. What causes hidradenitis suppurativa? -15 years after. Exp Dermatol. 2020;29(12):1154–1170

30. Karagiannidis I, Nikolakis G, Zouboulis CC. Endocrinologic aspects of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):45–49

31. Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ. 1989;298(6665):28–29

32. Lewis F, Messenger AG, Wales JK. Hidradenitis suppurativa as a presenting feature of premature adrenarche. Br J Dermatol. 1993;129(4):447–448

33. Liy-Wong C, Pope E, Lara-Corrales I. Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol.2015;73(5 suppl 1):S36–S41

34. Choi E, Ooi XT, Chandran NS. Hidradenitis suppurativa in pediatric patients. J Am Acad Dermatol. 2022;86(1):140–147

35. Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020;82(5): 1045–1058

36. Ingram JR. The genetics of hidradenitis suppurativa. Dermatol Clin. 2016;34(1):23–28

37. Frew JW, Navrazhina K. No evidence that impaired Notch signaling differentiates hidradenitis suppurativa from other inflammatory skin diseases. Br J Dermatol. 2020;182(4):1042–1043

38. Vaiopoulos AG, Nikolakis G, Zouboulis CC. Hidradenitis suppurativa in paediatric patients: a retrospective monocentric study in Germany and review of the literature. J Eur Acad Dermatol Venereol.2020;34(9):2140–2146

39. Seivright J, Collier E, Grogan T, et al. Pediatric hidradenitis suppurativa: epidemiology, disease presentation, and treatments. J Dermatolog Treat. 2022;33(4):2391–2393

40. Riis PT, Saunte DM, Sigsgaard V, et al. Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients. Arch Dermatol Res. 2020;312(10):715–724

41. Bui H, Sayed C. A cross-sectional study of pediatric hidradenitis suppurativa and the value of the International Hidradenitis Suppurativa Severity Score System (IHS4) as a pediatric clinical trial inclusion criteria. Pediatr Dermatol.2022;39(5):689–694

42. Garcovich S, Fania L, Caposiena D, et al. Pediatric hidradenitis suppurativa: across-sectional study on clinical features and treatment approaches. JCutan Med Surg. 2022;26(2):127–134

43. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH Jr, eds. Dermatologic Surgery: Principles and Practice, 2nd ed. New York, NY: Marcel Dekker; 1996:623–645

44. Seivright JR, Collier E, Grogan T, Hogeling M, Shi VY, Hsiao JL. Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: a retrospective analysis. Pediatr Dermatol. 2021;38(5): 1132–1136

45. Tiri H, Jokelainen J, Timonen M, Tasanen K, Huilaja L. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol. 2018;79(3):514–519

46. Toledo I, Lee SS, Park HH, Vuong C, Conic

RRZ, Hightower GK. A visit guide for adolescent hidradenitis suppurativa: bridging the divide between pediatric and adult care. JAAD Int. 2022;6:84–85

47. Garg A, Malviya N, Strunk A, et al. Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2022;86(5): 1092–1101

48. Balgobind A, Finelt N, Strunk A, Garg A. Association between obesity and hidradenitis suppurativa among children and adolescents: a population-based analysis in the United States. J Am Acad Dermatol. 2020;82(2):502–504

49. Edigin E, Eseaton PO. A report of 1290 pediatric hidradenitis suppurativa hospitalizations: a nationwide analysis from the Kids’ Inpatient Database. J Am Acad Dermatol. 2022;86(6):1446–1449

50. Choi E, Cook AR, Chandran NS. Hidradenitis suppurativa: an Asian perspective from a Singaporean institute. Skin Appendage Disord. 2018;4(4):281–285

51. Reichert B, Fernandez Faith E, Harfmann K. Weight counseling in pediatric hidradenitis suppurativa patients. Pediatr Dermatol. 2020;37(3):480–483

52. Magge SN, Goodman E, Armstrong SC; Committee on Nutrition; Section on Endocrinology; Section on Obesity. The metabolic syndrome in children and adolescents: shifting the focus to cardiometabolic risk factor clustering. Pediatrics. 2017;140(2):e20171603

53. Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019; 9(9):e030579

54. Wright S, Strunk A, Garg A. New-onset depression among children, adolescents, and adults with hidradenitis suppurativa. J Am Acad Dermatol. 2020;83(5): 1360–1366

55. McAndrew R, Lopes FCPS, Sebastian K, Diaz LZ. Quality of life in hidradenitis suppurativa: a cross-sectional study of a pediatric population. J Am Acad Dermatol. 2021;84(3):829–830

56. Patel KR, Rastogi S, Singam V, Lee HH, Amin AZ, Silverberg JI. Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample. Br J Dermatol. 2019;181(2):275–281

57. Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015;29(2):371–376

58. Lindsø Andersen P, Kromann C, Fonvig CE, Theut Riis P, Jemec GBE, Holm JC. Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents. Int J Dermatol. 2020;59(1):47–51

59. Bettoli V, Ricci M, Zauli S, Virgili A. Hidradenitis suppurativa-acne inversa: a relevant dermatosis in paediatric patients. Br J Dermatol. 2015;173(5):1328–1330

60. Jourdain JC, Le Lorier B, Mourier C, Ploussard JP, Roussel F. Virilization caused by 21-hydroxylase deficiency and axillary sweat gland hyperplasia [in French]. Ann Dermatol Venereol. 1988;115(11):1136–1138

61. Palmer RA, Keefe M. Early-onset hidradenitis suppurativa. Clin Exp Dermatol. 2001;26(6):501–503

62. Mengesha YM, Holcombe TC, Hansen RC. Prepubertal hidradenitis suppurativa: two case reports and review of the literature. Pediatr Dermatol. 1999;16(4):292–296

63. Torres-Zegarra C, Sundararajan D, Benson J, et al. Care for adolescents with polycystic ovary syndrome: development and prescribing patterns of a multidisciplinary clinic. J Pediatr Adolesc Gynecol. 2021;34(5):617–625

64. Kimball AB, Sundaram M, Gauthier G, et al. The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis. Dermatol Ther (Heidelb). 2018;8(4):557–569